Picard Medical, Inc. Revenue from Contract with Customer, Excluding Assessed Tax
Picard Medical, Inc. (PMI) reported Revenue from Contract with Customer, Excluding Assessed Tax of $2.95 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-19.
Financial Statements › Income Statement › Revenue
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax · last filed 2026-08-19
- Picard Medical, Inc. revenue from contract with customer, excluding assessed tax for the quarter ending 2026-06-30 was $2.95M, a 38.62% increase year-over-year.
- Picard Medical, Inc. revenue from contract with customer, excluding assessed tax for the quarter ending 2026-03-31 was $1.15M, a 85.48% increase year-over-year.
- Picard Medical, Inc. revenue from contract with customer, excluding assessed tax for the quarter ending 2025-12-31 was $1.01M, a 20.69% increase year-over-year.
- Picard Medical, Inc. revenue from contract with customer, excluding assessed tax for the quarter ending 2025-09-30 was $1.19M, a 34.73% increase year-over-year.
| Period end | Revenue from Contract with Customer, Excluding Assessed Tax 3 month | Revenue from Contract with Customer, Excluding Assessed Tax 6 month | Revenue from Contract with Customer, Excluding Assessed Tax 9 month | Revenue from Contract with Customer, Excluding Assessed Tax 12 month |
|---|---|---|---|---|
| 2026-06-30 | $2.95M 10-Q · filed 2026-08-19 | $4.10M 10-Q · filed 2026-08-19 | $5.11M derived: sum of 3 quarters · filed 2026-08-19 | $6.30M derived: sum of 4 quarters · filed 2026-08-19 |
| 2026-03-31 | $1.15M 10-Q · filed 2026-05-15 | $2.16M derived: sum of 2 quarters · filed 2026-05-15 | $3.35M derived: sum of 3 quarters · filed 2026-05-15 | $5.48M derived: sum of 4 quarters · filed 2026-08-19 |
| 2025-12-31 | $1.01M derived: S-1/A 12 month − 10-Q 9 month · filed 2026-05-01 | $2.20M derived: sum of 2 quarters · filed 2026-05-01 | $4.33M derived: sum of 3 quarters · filed 2026-08-19 | $4.94M S-1/A · filed 2026-05-01 |
| 2025-09-30 | $1.19M 10-Q · filed 2025-11-14 | $3.32M derived: sum of 2 quarters · filed 2026-08-19 | $3.93M 10-Q · filed 2025-11-14 | $4.77M derived: sum of 4 quarters · filed 2026-08-19 |
| 2025-06-30 | $2.13M 10-Q · filed 2026-08-19 | $2.74M 10-Q · filed 2026-08-19 | $3.59M derived: sum of 3 quarters · filed 2026-08-19 | $4.47M derived: sum of 4 quarters · filed 2026-08-19 |
| 2025-03-31 | $620.00K 10-Q · filed 2026-05-15 | $1.46M derived: sum of 2 quarters · filed 2026-05-15 | $2.34M derived: sum of 3 quarters · filed 2026-05-15 | |
| 2024-12-31 | $836.00K derived: S-1/A 12 month − 10-Q 9 month · filed 2026-05-01 | $1.72M derived: sum of 2 quarters · filed 2026-05-01 | $4.39M S-1/A · filed 2026-05-01 | |
| 2024-09-30 | $881.00K 10-Q · filed 2025-11-14 | $3.56M 10-Q · filed 2025-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEUROONE MEDICAL TECHNOLOGIES Corp (NMTC) | United States | $0.012B | |
| ALLURION TECHNOLOGIES, INC. (ALUR) | United States | $0.010B | |
| Sintx Technologies, Inc. (SINT) | United States | $0.012B | -1.10 |
| CERENOME, INC. (CNSY) | United States | $0.014B | |
| Co-Diagnostics, Inc. (CODX) | United States | $0.007B | -0.32 |
| SeaStar Medical Holding Corp (ICU) | United States | $0.015B | -1.14 |
| enVVeno Medical Corp (NVNO) | United States | $0.006B | -0.48 |
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B |